164 related articles for article (PubMed ID: 10697538)
1. Antiproliferative activity in vitro of side-chain analogues of calcitriol against various human normal and cancer cell lines.
Opolski A; Wietrzyk J; Chrobak A; Marcinkowska E; Wojdat E; Kutner A; Radzikowski C
Anticancer Res; 1999; 19(6B):5217-22. PubMed ID: 10697538
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative activity of vitamin D compounds in combination with cytostatics.
Pelczynska M; Switalska M; Maciejewska M; Jaroszewicz I; Kutner A; Opolski A
Anticancer Res; 2006; 26(4A):2701-5. PubMed ID: 16886680
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.
Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Uskokovic MR; Brenner RV; Evans SR
Cancer Res; 1994 Aug; 54(15):4057-64. PubMed ID: 8033137
[TBL] [Abstract][Full Text] [Related]
4. Correlation between VDR expression and antiproliferative activity of vitamin D3 compounds in combination with cytostatics.
Pelczynska M; Wietrzyk J; Jaroszewicz I; Nevozhay D; Switalska M; Kutner A; Zabel M; Opolski A
Anticancer Res; 2005; 25(3B):2235-40. PubMed ID: 16158969
[TBL] [Abstract][Full Text] [Related]
5. Antitumor properties of diastereomeric and geometric analogs of vitamin D3.
Wietrzyk J; Chodyński M; Fitak H; Wojdat E; Kutner A; Opolski A
Anticancer Drugs; 2007 Apr; 18(4):447-57. PubMed ID: 17351397
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of the antiproliferative effect in vitro of doxorubicin, cisplatin and genistein by new analogues of vitamin D.
Siwińska A; Opolski A; Chrobak A; Wietrzyk J; Wojdat E; Kutner A; Szelejewski W; Radzikowski C
Anticancer Res; 2001; 21(3B):1925-9. PubMed ID: 11497279
[TBL] [Abstract][Full Text] [Related]
7. The influence of 1,25-dihydroxyvitamin D3 and 1,24-dihydroxyvitamin D3 on alphavbeta3 integrin expression in cancer cell lines.
Wietrzyk J; Filip B; Milczarek M; Klopotowska D; Maciejewska M; Dabrowska K; Kurzepa A; Dzimira S; Madej J; Kutner A
Oncol Rep; 2008 Oct; 20(4):941-52. PubMed ID: 18813838
[TBL] [Abstract][Full Text] [Related]
8. Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion.
Hedlund TE; Moffatt KA; Uskokovic MR; Miller GJ
Clin Cancer Res; 1997 Aug; 3(8):1331-8. PubMed ID: 9815816
[TBL] [Abstract][Full Text] [Related]
9. Side-chain-modified analogs of calcitriol cause resistance of human HL-60 promyelocytic leukemia cells to drug-induced apoptosis.
Chrobak A; Radzikowski C; Opolski A
Steroids; 2005 Jan; 70(1):19-27. PubMed ID: 15610893
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
[TBL] [Abstract][Full Text] [Related]
11. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
Konety BR; Lavelle JP; Pirtskalaishvili G; Dhir R; Meyers SA; Nguyen TS; Hershberger P; Shurin MR; Johnson CS; Trump DL; Zeidel ML; Getzenberg RH
J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420
[TBL] [Abstract][Full Text] [Related]
12. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
13. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.
Wietrzyk J; Nevozhay D; Milczarek M; Filip B; Kutner A
Cancer Chemother Pharmacol; 2008 Oct; 62(5):787-97. PubMed ID: 18188568
[TBL] [Abstract][Full Text] [Related]
14. 1alpha,25-Dihydroxyvitamin D3-3beta-(2)-bromoacetate, an affinity labeling derivative of 1alpha,25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells.
Swamy N; Persons KS; Chen TC; Ray R
J Cell Biochem; 2003 Aug; 89(5):909-16. PubMed ID: 12874825
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative and angiostatic activity of suramin analogues.
Firsching A; Nickel P; Mora P; Allolio B
Cancer Res; 1995 Nov; 55(21):4957-61. PubMed ID: 7585536
[TBL] [Abstract][Full Text] [Related]
16. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
[TBL] [Abstract][Full Text] [Related]
17. Biological activity in vitro of side-chain modified analogues of calcitriol.
Opolski A; Wietrzyk J; Siwinska A; Marcinkowska E; Chrobak A; Radzikowski C; Kutner A
Curr Pharm Des; 2000 May; 6(7):755-65. PubMed ID: 10828306
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: cis-perhydrindane CE-ring analogues.
Demin S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R; Verstuyf A
Bioorg Med Chem Lett; 2004 Aug; 14(15):3885-8. PubMed ID: 15225690
[TBL] [Abstract][Full Text] [Related]
19. Differential apoptotic response of human melanoma cells to 1 alpha,25-dihydroxyvitamin D3 and its analogues.
Danielsson C; Fehsel K; Polly P; Carlberg C
Cell Death Differ; 1998 Nov; 5(11):946-52. PubMed ID: 9846181
[TBL] [Abstract][Full Text] [Related]
20. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
